Penn Medicine researchers receive prestigious NIH 2021 Director’s Awards
The grants, totaling more than $8 million, will support seven high-risk, high-reward research projects
PCI and JPOD included in the Technical.ly Philly list of resources to boost Philly health startups
A list of Penn programs, partners and friends that work together to support new health startups in the Philadelphia region.
Former I-Corps company making breast pumping easier for moms
Adriana Vazquez spent years perfecting her breast pumping bra for company Lilu.
Interius BioTherapeutics Moves to Pennovation Lab
In October 2021, Interius BioTherapeutics (“Interius”) signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Washington Post special features on mRNA foundational technology inventors
The Washington Post ran two feature articles profiling Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery.
Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for Biomedical Research
The foundational work that enabled the use of messenger RNA (mRNA) in vaccine development that they're receiving the 2021 Dr. Paul Janssen Award for Biomedical Research,
Penn mRNA Scientists Drew Weissman and Katalin Karikó Receive 2021 Lasker Award, America’s Top Biomedical Research Prize
Drs. Weissman and Karikó’s mRNA technology is recognized for enabling rapid development of highly effective COVID-19 vaccines.
Penn establishes the Center for Precision Engineering for Health with $100 million commitment
Penn announced that it has made a $100 million commitment in its School of Engineering and Applied Science to establish the Center for Precision Engineering for Health.
Philly just ranked high on a global list of startup ecosystems. These local leaders aren’t surprised
iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.
Luxturna inventor Jean Bennett starts a new gene therapy company to tackle rare diseases left behind by pharma, VCs
Jean Bennett, who designed and co-developed Luxturna, approved in 2018 for a rare form of blindness, had kept building new gene therapies for eye diseases at her University of Pennsylvania lab.